Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

HDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1α, and Hsc70.

Luo L, Martin SC, Parkington J, Cadena SM, Zhu J, Ibebunjo C, Summermatter S, Londraville N, Patora-Komisarska K, Widler L, Zhai H, Trendelenburg AU, Glass DJ, Shi J.

Cell Rep. 2019 Oct 15;29(3):749-763.e12. doi: 10.1016/j.celrep.2019.09.023.

2.

mTORC1 and PKB/Akt control the muscle response to denervation by regulating autophagy and HDAC4.

Castets P, Rion N, Théodore M, Falcetta D, Lin S, Reischl M, Wild F, Guérard L, Eickhorst C, Brockhoff M, Guridi M, Ibebunjo C, Cruz J, Sinnreich M, Rudolf R, Glass DJ, Rüegg MA.

Nat Commun. 2019 Jul 18;10(1):3187. doi: 10.1038/s41467-019-11227-4.

3.

An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy.

Lach-Trifilieff E, Minetti GC, Sheppard K, Ibebunjo C, Feige JN, Hartmann S, Brachat S, Rivet H, Koelbing C, Morvan F, Hatakeyama S, Glass DJ.

Mol Cell Biol. 2014 Feb;34(4):606-18. doi: 10.1128/MCB.01307-13. Epub 2013 Dec 2.

4.

Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia.

Ibebunjo C, Chick JM, Kendall T, Eash JK, Li C, Zhang Y, Vickers C, Wu Z, Clarke BA, Shi J, Cruz J, Fournier B, Brachat S, Gutzwiller S, Ma Q, Markovits J, Broome M, Steinkrauss M, Skuba E, Galarneau JR, Gygi SP, Glass DJ.

Mol Cell Biol. 2013 Jan;33(2):194-212. doi: 10.1128/MCB.01036-12. Epub 2012 Oct 29.

5.

MNK2 inhibits eIF4G activation through a pathway involving serine-arginine-rich protein kinase in skeletal muscle.

Hu SI, Katz M, Chin S, Qi X, Cruz J, Ibebunjo C, Zhao S, Chen A, Glass DJ.

Sci Signal. 2012 Feb 14;5(211):ra14. doi: 10.1126/scisignal.2002466.

6.

The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling.

Shi J, Luo L, Eash J, Ibebunjo C, Glass DJ.

Dev Cell. 2011 Nov 15;21(5):835-47. doi: 10.1016/j.devcel.2011.09.011. Epub 2011 Oct 25.

7.

Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice.

Murphy KT, Cobani V, Ryall JG, Ibebunjo C, Lynch GS.

J Appl Physiol (1985). 2011 Apr;110(4):1065-72. doi: 10.1152/japplphysiol.01183.2010. Epub 2011 Jan 26.

8.

Voluntary running, skeletal muscle gene expression, and signaling inversely regulated by orchidectomy and testosterone replacement.

Ibebunjo C, Eash JK, Li C, Ma Q, Glass DJ.

Am J Physiol Endocrinol Metab. 2011 Feb;300(2):E327-40. doi: 10.1152/ajpendo.00402.2010. Epub 2010 Nov 2.

9.

Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function.

Murphy KT, Koopman R, Naim T, Léger B, Trieu J, Ibebunjo C, Lynch GS.

FASEB J. 2010 Nov;24(11):4433-42. doi: 10.1096/fj.10-159608. Epub 2010 Jul 12.

PMID:
20624929
10.

Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice.

Murphy KT, Ryall JG, Snell SM, Nair L, Koopman R, Krasney PA, Ibebunjo C, Holden KS, Loria PM, Salatto CT, Lynch GS.

Am J Pathol. 2010 May;176(5):2425-34. doi: 10.2353/ajpath.2010.090932. Epub 2010 Apr 2.

11.

Myostatin expression in age and denervation-induced skeletal muscle atrophy.

Baumann AP, Ibebunjo C, Grasser WA, Paralkar VM.

J Musculoskelet Neuronal Interact. 2003 Mar;3(1):8-16.

12.

Malignant astrocytoma with binucleated granular cells in a Sprague-Dawley rat.

Pruimboom-Brees IM, Brees DJ, Shen AC, Ibebunjo C.

Vet Pathol. 2004 May;41(3):287-90.

PMID:
15133182
13.

Disparate dysfunction of skeletal muscles located near and distant from burn site in the rat.

Ibebunjo C, Martyn J.

Muscle Nerve. 2001 Oct;24(10):1283-94.

PMID:
11562907
14.

Long-term denervation impairs insulin receptor substrate-1-mediated insulin signaling in skeletal muscle.

Hirose M, Kaneki M, Sugita H, Yasuhara S, Ibebunjo C, Martyn JA.

Metabolism. 2001 Feb;50(2):216-22. Erratum in: Metabolism 2001 May;50(5):619. Iebunjo C [corrected to Ibebunjo C].

PMID:
11229432
15.
16.

Prednisolone-induced muscle dysfunction is caused more by atrophy than by altered acetylcholine receptor expression.

Shin YS, Fink H, Khiroya R, Ibebunjo C, Martyn J.

Anesth Analg. 2000 Aug;91(2):322-8.

PMID:
10910842
17.

Morphological correlates of the differential responses of muscles to vecuronium.

Ibebunjo C, Srikant CB, Donati F.

Br J Anaesth. 1999 Aug;83(2):284-91.

18.
19.

Mechanisms for the paradoxical resistance to d-tubocurarine during immobilization-induced muscle atrophy.

Ibebunjo C, Nosek MT, Itani MS, Martyn JA.

J Pharmacol Exp Ther. 1997 Nov;283(2):443-51.

PMID:
9353356
20.

Tacrine does not alter the potency of succinylcholine in the rat.

Ibebunjo C, Eshelby D, Donati F, Fox GS, Tchervenkov JI.

Can J Anaesth. 1997 Sep;44(9):1021-6.

PMID:
9305568
21.

The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the rat.

Ibebunjo C, Donati F, Fox GS, Eshelby D, Tchervenkov JI.

Anesth Analg. 1997 Aug;85(2):431-6.

PMID:
9249126
23.
24.
25.

Muscle fibre diameter and sensitivity to neuromuscular blocking drugs.

Ibebunjo C, Hall LW.

Br J Anaesth. 1993 Nov;71(5):732-3.

26.
27.
28.

Comparison of the effects of cassava (Manihot esculenta Crantz) organic cyanide and inorganic cyanide on muscle and bone development in a Nigerian breed of dog.

Ibebunjo C, Kamalu BP, Ihemelandu EC.

Br J Nutr. 1992 Sep;68(2):483-91. Erratum in: Br J Nutr 1993 Jan;69(1):following 299.

PMID:
1445827
29.

Supplemental Content

Loading ...
Support Center